iPSC-derived next-generation T cell therapy for refractory tumors

被引：0
|
作者：
Ando, M. [1 ]
机构：
[1] Juntendo Univ, Sch Med, Dept Hematol, Tokyo, Japan
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷
关键词：
D O I：
10.1016/j.annonc.2024.07.672
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
SY9-3
引用
收藏
页码：S1288 / S1288
页数：1
相关论文
共 50 条
  • [1] Generation of an iPSC-derived hepatic organoid for liver cell therapy
    Trionfini, P.
    Romano, E.
    Varinelli, M.
    Longarett, L.
    Caroli, A.
    Moretti, S.
    Tomasoni, S.
    HUMAN GENE THERAPY, 2024, 35 (3-4) : A135 - A135
  • [2] Development of Next-Generation NK Cell Optimized Chimeric Antigen Receptors (CARs) for iPSC-Derived NK Cell Therapies Targeting Both Solid and Liquid Tumors
    Swanson, Lee
    Lyon, Kenyon
    Tadros, Wael
    Loreti, Mafalda
    Babin, Tammy
    Blair, Benjamin
    Schabla, Max
    Sideras, Paschalis
    Kaufman, Dan S.
    Hollingsworth, Robert
    Zhu, Huang
    BLOOD, 2022, 140 : 4540 - 4541
  • [3] Next-generation regulatory T cell therapy
    Leonardo M. R. Ferreira
    Yannick D. Muller
    Jeffrey A. Bluestone
    Qizhi Tang
    Nature Reviews Drug Discovery, 2019, 18 : 749 - 769
  • [4] Next-generation regulatory T cell therapy
    Ferreira, Leonardo M. R.
    Muller, Yannick D.
    Bluestone, Jeffrey A.
    Tang, Qizhi
    NATURE REVIEWS DRUG DISCOVERY, 2019, 18 (10) : 749 - 769
  • [5] Dual-antigen targeted iPSC-derived chimeric antigen receptor-T cell therapy for refractory lymphoma
    Harada, Sakiko
    Ando, Miki
    Ando, Jun
    Ishii, Midori
    Yamaguchi, Tomoyuki
    Yamazaki, Satoshi
    Toyota, Tokuko
    Ohara, Kazuo
    Ohtaka, Manami
    Nakanishi, Mahito
    Shin, Chansu
    Ota, Yasunori
    Nakashima, Kazutaka
    Ohshima, Koichi
    Imai, Chihaya
    Nakazawa, Yozo
    Nakauchi, Hiromitsu
    Komatsu, Norio
    MOLECULAR THERAPY, 2022, 30 (02) : 534 - 549
  • [6] Development of iPSC-derived CAR-T and CAR-NK cell therapy
    Kaneko, Shin
    CANCER SCIENCE, 2025, 116 : 1786 - 1786
  • [7] Discovery of a novel Nectin4 IPSC-derived cell therapy for the treatment of solid tumors
    Carton, Jill M.
    Dower, Chris
    Miller, Michael
    Wheeler, John
    Heron, Sean
    Millar, Hillary J.
    Walker, David
    Perry, Daniel J.
    Lebid, Andriana
    Cocka, Luis
    Kim, Dae Hwan
    Morse, Barry
    Gurung, Buddha
    Harris, Maisha
    Jethon, Annalise
    Naso, Michael
    Levitsky, Hy
    CANCER RESEARCH, 2024, 84 (06)
  • [8] Emerging NK cell therapies for cancer and the promise of next generation engineering of iPSC-derived NK cells
    Maddineni, Sainiteesh
    Silberstein, John L.
    Sunwoo, John B.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (05)
  • [9] A next-generation iPSC-derived forebrain organoid model of tauopathy with tau fibrils by AAV-mediated gene transfer
    Shimada, Hiroko
    Sato, Yuta
    Sasaki, Takashi
    Shimozawa, Aki
    Imaizumi, Kent
    Shindo, Tomoko
    Miyao, Sachiyo
    Kiyama, Kosuke
    Kondo, Takahiro
    Shibata, Shinsuke
    Ishii, Seiji
    Kuromitsu, Junro
    Aoyagi, Hirofumi
    Ito, Daisuke
    Okano, Hideyuki
    CELL REPORTS METHODS, 2022, 2 (09):
  • [10] Generation and manipulation of human iPSC-derived platelets
    Sugimoto, Naoshi
    Eto, Koji
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2021, 78 (07) : 3385 - 3401
12345